Periodic active case finding for TB: when to look?
OBJECTIVE
To investigate the factors influencing the performance and cost-efficacy of periodic rounds of active case finding (ACF) for TB.


METHODS
A mathematical model of TB dynamics and periodic ACF (PACF) in the HIV era, simplified by assuming constant prevalence of latent TB infection, is analyzed for features that control intervention outcome, measured as cases averted and cases found. Explanatory variables include baseline TB incidence, interval between PACF rounds, and different routine and PACF case-detection rates among HIV-infected and uninfected TB cases.


RESULTS
PACF can be cost-saving over a 10 year time frame if the cost-per-round is lower than a threshold proportional to initial incidence and cost-per-case-treated. More cases are averted at higher baseline incidence rates, when more potent PACF strategies are used, intervals between PACF rounds are shorter, and when the ratio of HIV-negative to positive TB cases detected is higher. More costly approaches, e.g. radiographic screening, can be as cost-effective as less costly alternatives if PACF case-detection is higher and/or implementation less frequent.


CONCLUSIONS
Periodic ACF can both improve control and save medium-term health care costs in high TB burden settings. Greater costs of highly effective PACF at frequent (e.g. yearly) intervals may be offset by higher numbers of cases averted in populations with high baseline TB incidence, higher prevalence of HIV-uninfected cases, higher costs per-case-treated, and more effective routine case-detection. Less intensive approaches may still be cost-neutral or cost-saving in populations lacking one or more of these key determinants.
London School of Hygiene and Tropical Medicine, London, United Kingdom. peter.dodd@lshtm.ac.uk
Peter J
PJ
Dodd
Richard G
RG
White
Elizabeth L
EL
Corbett
D015658:HIV Infections / Q000150:complications; D017048:Health Care Costs; D006801:Humans; D015994:Incidence; D008962:Models, Theoretical; D015995:Prevalence; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology